Table of Content

1 Market Overview of Artificial Joint Infection Treatment
1.1 Artificial Joint Infection Treatment Market Overview
1.1.1 Artificial Joint Infection Treatment Product Scope
1.1.2 Artificial Joint Infection Treatment Market Status and Outlook
1.2 Global Artificial Joint Infection Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Artificial Joint Infection Treatment Market Size by Region (2018-2029)
1.4 Global Artificial Joint Infection Treatment Historic Market Size by Region (2018-2024)
1.5 Global Artificial Joint Infection Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Artificial Joint Infection Treatment Market Size (2018-2029)
1.6.1 North America Artificial Joint Infection Treatment Market Size (2018-2029)
1.6.2 Europe Artificial Joint Infection Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Artificial Joint Infection Treatment Market Size (2018-2029)
1.6.4 Latin America Artificial Joint Infection Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Artificial Joint Infection Treatment Market Size (2018-2029)
2 Artificial Joint Infection Treatment Market by Type
2.1 Introduction
2.1.1 Aminoglycosides
2.1.2 Glycopeptides
2.1.3 Rifamycin
2.1.4 Lincosamide
2.1.5 Penicillin
2.1.6 Others
2.2 Global Artificial Joint Infection Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Artificial Joint Infection Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Artificial Joint Infection Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Artificial Joint Infection Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Artificial Joint Infection Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Artificial Joint Infection Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Artificial Joint Infection Treatment Revenue Breakdown by Type (2018-2029)
3 Artificial Joint Infection Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Artificial Joint Infection Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Artificial Joint Infection Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Artificial Joint Infection Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Artificial Joint Infection Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Artificial Joint Infection Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Artificial Joint Infection Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Artificial Joint Infection Treatment Revenue Breakdown by Application (2018-2029)
4 Artificial Joint Infection Treatment Competition Analysis by Players
4.1 Global Artificial Joint Infection Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
4.3 Date of Key Players Enter into Artificial Joint Infection Treatment Market
4.4 Global Top Players Artificial Joint Infection Treatment Headquarters and Area Served
4.5 Key Players Artificial Joint Infection Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Artificial Joint Infection Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Arrevus
5.1.1 Arrevus Profile
5.1.2 Arrevus Main Business
5.1.3 Arrevus Artificial Joint Infection Treatment Products, Services and Solutions
5.1.4 Arrevus Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 Arrevus Recent Developments
5.2 MELINTA THERAPEUTICS, INC.
5.2.1 MELINTA THERAPEUTICS, INC. Profile
5.2.2 MELINTA THERAPEUTICS, INC. Main Business
5.2.3 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Products, Services and Solutions
5.2.4 MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 MELINTA THERAPEUTICS, INC. Recent Developments
5.3 Nabriva Therapeutics plc
5.3.1 Nabriva Therapeutics plc Profile
5.3.2 Nabriva Therapeutics plc Main Business
5.3.3 Nabriva Therapeutics plc Artificial Joint Infection Treatment Products, Services and Solutions
5.3.4 Nabriva Therapeutics plc Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.3.5 Peptilogics Recent Developments
5.4 Peptilogics
5.4.1 Peptilogics Profile
5.4.2 Peptilogics Main Business
5.4.3 Peptilogics Artificial Joint Infection Treatment Products, Services and Solutions
5.4.4 Peptilogics Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.4.5 Peptilogics Recent Developments
5.5 Telephus Medical LLC
5.5.1 Telephus Medical LLC Profile
5.5.2 Telephus Medical LLC Main Business
5.5.3 Telephus Medical LLC Artificial Joint Infection Treatment Products, Services and Solutions
5.5.4 Telephus Medical LLC Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.5.5 Telephus Medical LLC Recent Developments
5.6 TenNor Therapeutics Ltd
5.6.1 TenNor Therapeutics Ltd Profile
5.6.2 TenNor Therapeutics Ltd Main Business
5.6.3 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Products, Services and Solutions
5.6.4 TenNor Therapeutics Ltd Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.6.5 TenNor Therapeutics Ltd Recent Developments
5.7 Cempra Inc
5.7.1 Cempra Inc Profile
5.7.2 Cempra Inc Main Business
5.7.3 Cempra Inc Artificial Joint Infection Treatment Products, Services and Solutions
5.7.4 Cempra Inc Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.7.5 Cempra Inc Recent Developments
5.8 Motif Bio Plc
5.8.1 Motif Bio Plc Profile
5.8.2 Motif Bio Plc Main Business
5.8.3 Motif Bio Plc Artificial Joint Infection Treatment Products, Services and Solutions
5.8.4 Motif Bio Plc Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.8.5 Motif Bio Plc Recent Developments
5.9 Johnson & Johnson Services
5.9.1 Johnson & Johnson Services Profile
5.9.2 Johnson & Johnson Services Main Business
5.9.3 Johnson & Johnson Services Artificial Joint Infection Treatment Products, Services and Solutions
5.9.4 Johnson & Johnson Services Artificial Joint Infection Treatment Revenue (US$ Million) & (2018-2024)
5.9.5 Johnson & Johnson Services Recent Developments
6 North America
6.1 North America Artificial Joint Infection Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Artificial Joint Infection Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Artificial Joint Infection Treatment Market Dynamics
11.1 Artificial Joint Infection Treatment Industry Trends
11.2 Artificial Joint Infection Treatment Market Drivers
11.3 Artificial Joint Infection Treatment Market Challenges
11.4 Artificial Joint Infection Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Artificial Joint Infection Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Artificial Joint Infection Treatment Market Size Share by Region (2018-2024)
Table 4. Global Artificial Joint Infection Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Artificial Joint Infection Treatment Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Artificial Joint Infection Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Artificial Joint Infection Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global Artificial Joint Infection Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Artificial Joint Infection Treatment Revenue Market Share by Type (2024-2029)
Table 11. North America Artificial Joint Infection Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Artificial Joint Infection Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Artificial Joint Infection Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Artificial Joint Infection Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Artificial Joint Infection Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Artificial Joint Infection Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Artificial Joint Infection Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Artificial Joint Infection Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Artificial Joint Infection Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Artificial Joint Infection Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Artificial Joint Infection Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Artificial Joint Infection Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global Artificial Joint Infection Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Artificial Joint Infection Treatment Revenue Market Share by Application (2024-2029)
Table 26. North America Artificial Joint Infection Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Artificial Joint Infection Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Artificial Joint Infection Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Artificial Joint Infection Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Artificial Joint Infection Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Artificial Joint Infection Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Artificial Joint Infection Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Artificial Joint Infection Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Artificial Joint Infection Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Artificial Joint Infection Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Artificial Joint Infection Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Artificial Joint Infection Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Artificial Joint Infection Treatment as of 2022)
Table 39. Date of Key Players Enter into Artificial Joint Infection Treatment Market
Table 40. Global Artificial Joint Infection Treatment Key Players Headquarters and Area Served
Table 41. Artificial Joint Infection Treatment Product Solution and Service
Table 42. Global Artificial Joint Infection Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Arrevus Basic Information List
Table 45. Arrevus Description and Business Overview
Table 46. Arrevus Artificial Joint Infection Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Arrevus (2018-2024)
Table 48. Arrevus Recent Developments
Table 49. MELINTA THERAPEUTICS, INC. Basic Information List
Table 50. MELINTA THERAPEUTICS, INC. Description and Business Overview
Table 51. MELINTA THERAPEUTICS, INC. Artificial Joint Infection Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of MELINTA THERAPEUTICS, INC. (2018-2024)
Table 53. MELINTA THERAPEUTICS, INC. Recent Developments
Table 54. Nabriva Therapeutics plc Basic Information List
Table 55. Nabriva Therapeutics plc Description and Business Overview
Table 56. Nabriva Therapeutics plc Artificial Joint Infection Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Nabriva Therapeutics plc (2018-2024)
Table 58. Nabriva Therapeutics plc Recent Developments
Table 59. Peptilogics Basic Information List
Table 60. Peptilogics Description and Business Overview
Table 61. Peptilogics Artificial Joint Infection Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Peptilogics (2018-2024)
Table 63. Peptilogics Recent Developments
Table 64. Telephus Medical LLC Basic Information List
Table 65. Telephus Medical LLC Description and Business Overview
Table 66. Telephus Medical LLC Artificial Joint Infection Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Telephus Medical LLC (2018-2024)
Table 68. Telephus Medical LLC Recent Developments
Table 69. TenNor Therapeutics Ltd Basic Information List
Table 70. TenNor Therapeutics Ltd Description and Business Overview
Table 71. TenNor Therapeutics Ltd Artificial Joint Infection Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of TenNor Therapeutics Ltd (2018-2024)
Table 73. TenNor Therapeutics Ltd Recent Developments
Table 74. Cempra Inc Basic Information List
Table 75. Cempra Inc Description and Business Overview
Table 76. Cempra Inc Artificial Joint Infection Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Cempra Inc (2018-2024)
Table 78. Cempra Inc Recent Developments
Table 79. Motif Bio Plc Basic Information List
Table 80. Motif Bio Plc Description and Business Overview
Table 81. Motif Bio Plc Artificial Joint Infection Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Motif Bio Plc (2018-2024)
Table 83. Motif Bio Plc Recent Developments
Table 84. Johnson & Johnson Services Basic Information List
Table 85. Johnson & Johnson Services Description and Business Overview
Table 86. Johnson & Johnson Services Artificial Joint Infection Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Artificial Joint Infection Treatment Business of Johnson & Johnson Services (2018-2024)
Table 88. Johnson & Johnson Services Recent Developments
Table 89. North America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 90. North America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 91. Europe Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 92. Europe Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Artificial Joint Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 95. Asia-Pacific Artificial Joint Infection Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 96. Asia-Pacific Artificial Joint Infection Treatment Market Share by Region (2018-2024)
Table 97. Asia-Pacific Artificial Joint Infection Treatment Market Share by Region (2024-2029)
Table 98. Latin America Artificial Joint Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Latin America Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 100. Latin America Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 101. Middle East & Africa Artificial Joint Infection Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 102. Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 103. Middle East & Africa Artificial Joint Infection Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 104. Artificial Joint Infection Treatment Market Trends
Table 105. Artificial Joint Infection Treatment Market Drivers
Table 106. Artificial Joint Infection Treatment Market Challenges
Table 107. Artificial Joint Infection Treatment Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Joint Infection Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Artificial Joint Infection Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Artificial Joint Infection Treatment Market Share by Regions: 2022 VS 2029
Figure 4. Global Artificial Joint Infection Treatment Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Artificial Joint Infection Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Artificial Joint Infection Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Artificial Joint Infection Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Artificial Joint Infection Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Artificial Joint Infection Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Aminoglycosides
Figure 11. Global Aminoglycosides Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Glycopeptides
Figure 13. Global Glycopeptides Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Rifamycin
Figure 15. Global Rifamycin Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Lincosamide
Figure 17. Global Lincosamide Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Penicillin
Figure 19. Global Penicillin Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Product Picture of Others
Figure 21. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global Artificial Joint Infection Treatment Market Size Share by Type: 2022 & 2029
Figure 23. North America Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2029)
Figure 24. Europe Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2029)
Figure 25. Asia-Pacific Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2029)
Figure 26. Latin America Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2029)
Figure 27. Middle East and Africa Artificial Joint Infection Treatment Revenue Market Share by Type (2018-2029)
Figure 28. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 30. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 31. Global Artificial Joint Infection Treatment Market Size Share by Application: 2022 & 2029
Figure 32. North America Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2029)
Figure 33. Europe Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2029)
Figure 34. Asia-Pacific Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2029)
Figure 35. Latin America Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2029)
Figure 36. Middle East and Africa Artificial Joint Infection Treatment Revenue Market Share by Application (2018-2029)
Figure 37. Artificial Joint Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 38. Global Top 5 and Top 10 Players Artificial Joint Infection Treatment Market Share in 2022
Figure 39. North America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 40. United States Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 41. Canada Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 42. Germany Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 43. France Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 44. U.K. Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 45. Italy Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 46. Russia Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 47. Nordic Countries Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 48. Asia-Pacific Artificial Joint Infection Treatment Market Share by Region (2018-2029)
Figure 49. China Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 50. Japan Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 51. South Korea Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 52. Southeast Asia Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 53. India Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 54. Australia Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 55. Latin America Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 56. Mexico Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 57. Brazil Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 58. Middle East & Africa Artificial Joint Infection Treatment Market Share by Country (2018-2029)
Figure 59. Turkey Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 61. UAE Artificial Joint Infection Treatment Market Size (2018-2029) & (US$ Million)
Figure 62. Bottom-up and Top-down Approaches for This Report